Published in Cardiovasc Res on December 01, 2003
Dendritic cells in atherosclerotic disease. Clin Immunol (2009) 1.17
Analysis of arterial intimal hyperplasia: review and hypothesis. Theor Biol Med Model (2007) 0.98
A TAT-frataxin fusion protein increases lifespan and cardiac function in a conditional Friedreich's ataxia mouse model. Hum Mol Genet (2011) 0.94
Metabolic modulation and cellular therapy of cardiac dysfunction and failure. J Cell Mol Med (2009) 0.87
Progression of native coronary plaques and in-stent restenosis are associated and predicted by increased pre-procedural C reactive protein. Heart (2005) 0.87
Stainless steel ions stimulate increased thrombospondin-1-dependent TGF-beta activation by vascular smooth muscle cells: implications for in-stent restenosis. J Vasc Res (2009) 0.87
Macrophages, dendritic cells, and regression of atherosclerosis. Front Physiol (2012) 0.82
Identification of three prominin homologs and characterization of their messenger RNA expression in Xenopus laevis tissues. Mol Vis (2011) 0.77
Percutaneous coronary intervention causes a rapid but transient mobilisation of CD34(+)CD45(-) cells. Open Heart (2014) 0.76
Interventional procedures for atherothrombosis: pathology of retrieved material. Heart (2007) 0.75
Silent and apparent cerebral embolism after retrograde catheterisation of the aortic valve in valvular stenosis: a prospective, randomised study. Lancet (2003) 2.86
Patients with atrial fibrillation and dense spontaneous echo contrast at high risk a prospective and serial follow-up over 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Coll Cardiol (2005) 2.19
Dendritic cells in neointima formation after rat carotid balloon injury: coordinated expression withanti-apoptotic Bcl-2 and HSP47 in arterial repair. J Am Coll Cardiol (2003) 1.67
Persistence of iatrogenic atrial septal defect after pulmonary vein isolation--an underestimated risk? Am Heart J (2006) 1.63
In vitro comparison of platinum-iridium and gold tip electrodes: lesion depth in 4 mm, 8 mm, and irrigated-tip radiofrequency ablation catheters. Europace (2009) 1.61
Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J Cardiovasc Electrophysiol (2006) 1.60
Pseudomembranous and obstructive Aspergillus tracheobronchitis - optimal diagnostic strategy and outcome. Mycoses (2006) 1.58
Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial. Eur Heart J (2004) 1.58
Increased expression of C-reactive protein and tissue factor in acute coronary syndrome lesions: Correlation with serum C-reactive protein, angioscopic findings, and modification by statins. Atherosclerosis (2008) 1.48
Mechanical occlusion of the left atrial appendage. J Cardiovasc Electrophysiol (2003) 1.47
Radiation exposure during catheter ablation of atrial fibrillation. Circulation (2004) 1.44
Antiplatelet effects of antidepressant treatment: a randomized comparison between escitalopram and nortriptyline. Thromb Res (2010) 1.44
Gold-tip electrodes--a new "deep lesion" technology for catheter ablation? In vitro comparison of a gold alloy versus platinum-iridium tip electrode ablation catheter. J Cardiovasc Electrophysiol (2005) 1.41
Superiority of gold versus platinum irrigated tip catheter ablation of the pulmonary veins and the cavotricuspid isthmus: a randomized study comparing tip temperatures and cooling flow requirements. J Cardiovasc Electrophysiol (2012) 1.39
Left internal mammary angiography complicated by subclavian tortuosity: a technical note. J Interv Cardiol (2005) 1.39
Early outcome after implantation of Absorb bioresorbable drug-eluting scaffolds in patients with acute coronary syndromes. EuroIntervention (2014) 1.39
Identification of "substrate fibrillators" and "trigger fibrillators" by pacemaker diagnostics. Heart Rhythm (2006) 1.38
Comparison of cryoballoon and radiofrequency ablation of pulmonary veins in 40 patients with paroxysmal atrial fibrillation: a case-control study. J Cardiovasc Electrophysiol (2009) 1.35
Mean platelet volume as marker of restenosis after percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris. Thromb Res (2005) 1.27
The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. North American Society of Pacing and Electrophysiology/British Pacing and Electrophysiology Group. Pacing Clin Electrophysiol (2002) 1.24
Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation (2004) 1.09
Induction of atrial fibrillation in mice by rapid transesophageal atrial pacing. Basic Res Cardiol (2002) 1.09
D-Ribose improves diastolic function and quality of life in congestive heart failure patients: a prospective feasibility study. Eur J Heart Fail (2003) 1.03
Endothelial function assessment: flow-mediated dilation and constriction provide different and complementary information on the presence of coronary artery disease. Eur Heart J (2011) 1.02
Sequential patterns of chemokine- and chemokine receptor-synthesis following vessel wall injury in porcine coronary arteries. Atherosclerosis (2006) 1.02
An unusual case of pacemaker failure: complete disconnection of connector block and battery of a subpectorally implanted dual chamber pacemaker. Pacing Clin Electrophysiol (2002) 1.02
Deletion of the last five C-terminal amino acid residues of connexin43 leads to lethal ventricular arrhythmias in mice without affecting coupling via gap junction channels. Basic Res Cardiol (2013) 1.00
Atrial thrombi-a prospective follow-up study over 3 years with transesophageal echocardiography and cranial magnetic resonance imaging. Echocardiography (2006) 0.97
Cells of primarily extra-valvular origin in degenerative aortic valves and bioprostheses. Eur Heart J (2005) 0.97
Echocardiographic assessment of left ventricular mass in neonatal and adult mice: accuracy of different echocardiographic methods. Echocardiography (2006) 0.95
Real-Time Contrast Echo Assessment of Myocardial Perfusion at Low Emission Power: First Experimental and Clinical Results Using Power Pulse Inversion Imaging. Echocardiography (1999) 0.93
Atrioesophageal fistula after cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol (2012) 0.91
Changes of pulmonary vein orifice size and location throughout the cardiac cycle: dynamic analysis using magnetic resonance cine imaging. J Cardiovasc Electrophysiol (2005) 0.90
The complement component C5a is present in human coronary lesions in vivo and induces the expression of MMP-1 and MMP-9 in human macrophages in vitro. FASEB J (2010) 0.90
Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging. Am J Cardiol (2004) 0.89
Persistence of Chlamydia pneumoniae in degenerative aortic valve stenosis indicated by heat shock protein 60 homologues. J Heart Valve Dis (2003) 0.88
Harmonic Power Doppler Contrast Echocardiography: Preliminary Clinical Results. Echocardiography (1997) 0.88
Circumferential pulmonary vein mapping and ablation in focal atrial fibrillation: single catheter technique. J Interv Card Electrophysiol (2002) 0.88
Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves. J Heart Valve Dis (2008) 0.86
Use of transesophageal contrast echocardiography for excluding left atrial appendage thrombi in patients with atrial fibrillation before cardioversion. J Am Soc Echocardiogr (2002) 0.86
Degenerative valve disease and bioprostheses: risk assessment, predictive diagnosis, personalised treatments. EPMA J (2011) 0.85
Pathogen burden, inflammation, proliferation and apoptosis in human in-stent restenosis. Tissue characteristics compared to primary atherosclerosis. J Vasc Res (2004) 0.84
Improvement in Endocardial Border Delineation Using Tissue Harmonic Imaging. Echocardiography (1998) 0.84
Influence of the point of origin on heart rate turbulence after stimulated ventricular and atrial premature beats. Basic Res Cardiol (2003) 0.83
Peripheral hemorheological and vascular correlates of coronary blood flow. Clin Hemorheol Microcirc (2011) 0.83
Neointimal expression of rapamycin receptor FK506-binding protein FKBP12: postinjury animal and human in-stent restenosis tissue characteristics. J Vasc Res (2007) 0.83
Pathogen burden in degenerative aortic valves is associated with inflammatory and immune reactions. J Heart Valve Dis (2009) 0.82
Patients at high risk with atrial fibrillation: a prospective and serial follow-up during 12 months with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Soc Echocardiogr (2005) 0.82
Left atrial appendage occlusion in valvular atrial fibrillation following MitraClip implantation. Clin Res Cardiol (2012) 0.82
Impact of intimal pathogen burden in acute coronary syndromes--correlation with inflammation, thrombosis, and autoimmunity. Cardiovasc Pathol (2009) 0.82
Impact of age and basic heart rate on heart rate turbulence in healthy persons. Pacing Clin Electrophysiol (2005) 0.82
Impairment of the extrusion transporter for asymmetric dimethyl-L-arginine: a novel mechanism underlying vasospastic angina. Biochem Biophys Res Commun (2012) 0.82
Total beta-adrenoceptor knockout slows conduction and reduces inducible arrhythmias in the mouse heart. PLoS One (2012) 0.82
D-ribose aids congestive heart failure patients. Exp Clin Cardiol (2004) 0.81
Recovery from ultra-high dose organophosphate poisoning after "in-the-field" antidote treatment: potential lessons for civil defense. J Emerg Med (2008) 0.81
The Connexin40A96S mutation from a patient with atrial fibrillation causes decreased atrial conduction velocities and sustained episodes of induced atrial fibrillation in mice. J Mol Cell Cardiol (2013) 0.81
[Atrial fibrillation: stimulation and pacemaker therapy]. Herz (2002) 0.80
Prediction of degeneration of native and bioprosthetic aortic valves: issue-related particularities of diabetes mellitus. Infect Disord Drug Targets (2008) 0.80
Novel small leucine-rich repeat protein podocan is a negative regulator of migration and proliferation of smooth muscle cells, modulates neointima formation, and is expressed in human atheroma. Circulation (2013) 0.80
Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology. Expert Rev Med Devices (2006) 0.80
Myocardial contrast echocardiography enhances long-term prognostic value of supine bicycle stress two-dimensional echocardiography. J Am Soc Echocardiogr (2009) 0.80
Creatine phosphokinase elevation in obstructive sleep apnea syndrome: an unknown association? Chest (2006) 0.80
Immediate effect of the MitraClip procedure on mitral ring geometry in primary and secondary mitral regurgitation. Eur Heart J Cardiovasc Imaging (2013) 0.79
Differential antiplatelet effects of angiotensin converting enzyme inhibitors: comparison of ex vivo platelet aggregation in cardiovascular patients with ramipril, captopril and enalapril. Clin Res Cardiol (2006) 0.79
Naxos disease. J Interv Card Electrophysiol (2003) 0.79
Endothelial functions: Translating theory into clinical application. Clin Hemorheol Microcirc (2010) 0.79
Individualized selection of pacing algorithms for the prevention of recurrent atrial fibrillation: Results from the VIP registry. Pacing Clin Electrophysiol (2006) 0.79
Apoptosis-regulated survival of primarily extravascular cells in proliferative active poststent neointima. Cardiovasc Pathol (2009) 0.78
Impact of previous myocardial infarction on the incremental value of myocardial contrast to two-dimensional supine bicycle stress echocardiography in evaluation of coronary artery disease. Int J Cardiol (2009) 0.78
ECG signs mimicking acute inferior wall myocardial infarction are associated with elevated myocardial enzymes during isolation of pulmonary vein for focal atrial fibrillation. Europace (2004) 0.78
"Torsade de pointes" in patients with structural heart disease and atrial fibrillation treated with amiodarone, beta-blockers, and digitalis. Pacing Clin Electrophysiol (2006) 0.78
The imbalance between proliferation and apoptosis contributes to degeneration of aortic valves and bioprostheses. Cardiol J (2013) 0.78
Transient ST-segment-elevation during pulmonary vein ablation using circumferential coiled microelectrodes in a prospective multi-centre study. Europace (2006) 0.78
Atrial fibrillation: mortality, morbidity, and money; is that all? Importance and variability of burden measurement. Eur Heart J (2004) 0.78
Right Atrial Thrombi and Depressed Right Atrial Appendage Function After Cardioversion of Atrial Fibrillation. Echocardiography (1999) 0.78
Advanced pacemaker diagnostic features in the characterization of atrial fibrillation: impact on preventive pacing algorithms. Pacing Clin Electrophysiol (2003) 0.77
Influence of basic heart rate and sex on heart rate turbulence in healthy subjects. Pacing Clin Electrophysiol (2004) 0.77
Role of high frequency atrial pacing for the termination of acute atrial fibrillation and atypical atrial flutter. Pacing Clin Electrophysiol (2007) 0.77
Usefulness of 3D-PISA as compared to guideline endorsed parameters for mitral regurgitation quantification. Int J Cardiovasc Imaging (2014) 0.76
[Long-term outcome of intrapleural fibrinolytic therapy via small-bore catheter drainage in the management of complicated parapneumonic effusion and empyema-a case series]. Med Klin (Munich) (2005) 0.76
Incidence and rate characteristics of atrial tachyarrhythmias in patients with a dual chamber defibrillator. Pacing Clin Electrophysiol (2003) 0.76
Transesophageal contrast echocardiography distinguishes a left atrial appendage thrombus from spontaneous echo contrast. Echocardiography (2002) 0.76
Cells of primarily extravascular origin in neointima formation following stent implantation: coordinated expression of endothelial progenitor, dendritic and neural crest-derived cells. Cardiology (2007) 0.76
A prospective and randomized comparison of the safety and effects of therapeutic levels of enoxaparin versus unfractionated heparin in chronically anticoagulated patients undergoing elective cardiac catheterization. Thromb Haemost (2003) 0.76
Automatic p wave analysis over 24 hours in patients with paroxysmal or persistent atrial fibrillation. Ann Noninvasive Electrocardiol (2007) 0.76
Incidence of cerebral embolism after cardioversion of atrial fibrillation: a prospective study with transesophageal echocardiography and cerebral magnetic resonance imaging. J Am Soc Echocardiogr (2005) 0.76
Real time myocardial contrast echocardiography during supine bicycle stress and continuous infusion of contrast agent. Cutoff values for myocardial contrast replenishment discriminating abnormal myocardial perfusion. Echocardiography (2007) 0.76
Pro-arrhythmic effects of amiodarone and concomitant rate-control medication. Europace (2006) 0.76